Published in Haemophilia on January 01, 2009
Barriers and perceived limitations to early treatment of hemophilia. J Blood Med (2013) 1.04
Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates. Blood Transfus (2013) 0.99
Recombinant factor VIII in the management of hemophilia A: current use and future promise. Ther Clin Risk Manag (2009) 0.86
Redistribution and hemostatic action of recombinant activated factor VII associated with platelets. Am J Pathol (2011) 0.85
Revisiting hemophilia management in acute medicine. J Emerg Trauma Shock (2011) 0.82
Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors. J Blood Med (2010) 0.79
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients. Drug Des Devel Ther (2010) 0.77
Key issues in inhibitor management in patients with haemophilia. Blood Transfus (2013) 0.76
Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX. J Clin Med (2017) 0.75
Bypassing agent regimens and costs for prophylaxis in patients with inhibitors. Haemophilia (2009) 0.75
Animal models of FVIIa gene expression: their role in the future development of haemophilia treatment. Haemophilia (2010) 0.75
Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies. Leukemia (2006) 1.54
[Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy]. Neurologia (2006) 1.39
[The 2013 Seville Consensus Document on alternatives to allogenic blood transfusion. An update on the Seville Document]. Rev Esp Anestesiol Reanim (2013) 1.37
Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol (2007) 1.32
Retroperitoneal Castleman's disease. Surgery (1992) 1.28
Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg (1998) 1.20
Subacute electrical stimulation of the hippocampus blocks intractable temporal lobe seizures and paroxysmal EEG activities. Epilepsia (2000) 1.20
Phenotypic variability in familial prion diseases due to the D178N mutation. J Neurol Neurosurg Psychiatry (2005) 1.16
European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia (2007) 1.14
High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology (2004) 1.13
Effect of a new thienodiazepine (We-941) on sleep patterns of normal and insomniac subjects. Neuropharmacology (1981) 1.10
Sweet's syndrome and accelerated phase of chronic myelogenous leukemia. Ann Hematol (2000) 1.07
Centromedian-thalamic and hippocampal electrical stimulation for the control of intractable epileptic seizures. J Clin Neurophysiol (2001) 1.06
Human parvovirus B19 antibodies are less frequent among patients treated with factor IX concentrate inactivated by ultrafiltration: a report from a single Spanish institution. Vox Sang (1998) 1.06
Intrascleral schwannoma. Ophthalmologica (1976) 1.05
Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum (1997) 1.04
In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol (1997) 1.03
Influence of motor symptoms upon the quality of life of patients with Parkinson's disease. Eur Neurol (2007) 1.01
Traumatic aneurysm of a peripheral cerebral artery. Review and case report. J Neurosurg (1968) 1.00
Malignant solitary fibrous tumour of the orbit: report of a case with 8 years follow-up. Eye (Lond) (2001) 0.99
Left ventricular isovolumic velocity and duration variables calculated from colour-coded myocardial velocity images in normal individuals. Eur J Echocardiogr (2004) 0.96
Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement. Haemophilia (2004) 0.95
Therapeutic embolization and surgical excision of haemophilic pseudotumour. Haemophilia (1999) 0.93
Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor. J Clin Invest (1993) 0.93
Emergency perception and other variables associated with extra-hospital delay in stroke patients in the Maresme region (Spain). Eur J Neurol (2008) 0.91
Subacute and chronic electrical stimulation of the hippocampus on intractable temporal lobe seizures: preliminary report. Arch Med Res (2000) 0.91
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease. Br J Haematol (2001) 0.91
Successful thyroidectomy in a patient with Hermansky-Pudlak syndrome treated with recombinant activated factor VII and platelet concentrates. Blood Coagul Fibrinolysis (2002) 0.91
A quantitative evaluation of the effects of L-dopa on Parkinson's disease. Neuropharmacology (1973) 0.90
Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia (2004) 0.90
Acute and chronic electrical stimulation of the centromedian thalamic nucleus: modulation of reticulo-cortical systems and predictor factors for generalized seizure control. Arch Med Res (2000) 0.90
Neuromodulation of the inferior thalamic peduncle for major depression and obsessive compulsive disorder. Acta Neurochir Suppl (2007) 0.90
Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis. Eur J Heart Fail (2008) 0.89
Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency. Haemophilia (2000) 0.88
Osteopontin predicts long-term functional outcome among ischemic stroke patients. J Neurol (2010) 0.88
Prophylactic treatment effects on inhibitor risk: experience in one centre. Haemophilia (2005) 0.88
Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells. Thromb Haemost (1996) 0.87
Dementia, amyotrophy, and periodic complexes on the electroencephalogram: a diagnostic challenge. Arch Neurol (2001) 0.87
Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost (1999) 0.86
Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. J Thromb Haemost (2015) 0.86
Circulating levels of endothelial function are modulated by dietary monounsaturated fat. Atherosclerosis (1999) 0.86
Alumina cream-induced focal motor epilepsy in cats. 2. Thickness and cellularity of cerebral cortex adjacent to epileptogenic lesions. Epilepsia (1973) 0.86
Severe haemophilia A in a female resulting from an inherited gross deletion and a de novo codon deletion in the F8 gene. Haemophilia (2008) 0.86
Aortic thrombosis in a neonate with hereditary antithrombin III deficiency: successful outcome with thrombolytic and replacement treatment. Acta Paediatr (1996) 0.86
Resource utilization by deep-sea sharks at the Le Danois Bank, Cantabrian Sea, north-east Atlantic Ocean. J Fish Biol (2009) 0.85
The role of neuromodulation of the hippocampus in the treatment of intractable complex partial seizures of the temporal lobe. Acta Neurochir Suppl (2007) 0.85
[Baroreflex failure after chemodectoma resection]. Neurologia (2004) 0.85
Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA. Bone Marrow Transplant (1998) 0.85
Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects. Ann Hematol (1996) 0.84
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome. Ann Oncol (2003) 0.84
Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin. J Neurol (2012) 0.84
Cortical stimulation and epileptic seizure: a study of the potential risk in primates. Neurosurgery (1999) 0.84
Electrical stimulation of the centromedian thalamic nucleus in the treatment of convulsive seizures: a preliminary report. Epilepsia (1987) 0.84
Effect of fentanyl and naloxone on human somatic and auditory-evoked potential components. Neuropharmacology (1984) 0.83
Serum TNF levels in neonatal sepsis and septic shock. Acta Paediatr (1993) 0.83
Presumed melanocytoma of the macula. Arch Ophthalmol (1994) 0.83
Donor infection and transmission to the recipient of a solid allograft. Am J Transplant (2008) 0.83
Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation. Ann Hematol (2001) 0.83
C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand (2007) 0.83
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome. J Thromb Haemost (2006) 0.83
Gabapentin in late-onset poststroke seizures. Neurology (2002) 0.82
Plasma prolactin increase following electric stimulation of the amygdala in humans. Neuroendocrinology (1980) 0.82
Problem-solving abilities and frontal lobe cortical thickness in healthy aging and mild cognitive impairment. J Int Neuropsychol Soc (2010) 0.82
The role of tissue factor in the antiphospholipid syndrome. Arthritis Rheum (2001) 0.82
Yttrium-90 synoviorthesis for chronic haemophilic synovitis: Madrid experience. Haemophilia (2001) 0.81
Prophylaxis and treatment of chronic synovitis in haemophilia patients with inhibitors. Haemophilia (2007) 0.81
Spanish normative studies in young adults (NEURONORMA young adults project): norms for verbal fluency tests. Neurologia (2012) 0.81
Surgery in haemophilic patients with inhibitor: 20 years of experience. Haemophilia (2004) 0.81
Antithrombin III prevents early pulmonary dysfunction after lung transplantation in the dog. Circulation (2001) 0.81
[Seasonal variation of allergy-causing fungi in the southern part of Mexico City]. Allergol Immunopathol (Madr) (1986) 0.81
Tissue factor (TF) and urokinase plasminogen activator receptor (uPAR) and bleeding complications in leukemic patients. Thromb Haemost (1997) 0.81
Variability of soluble tissue factor in primary antiphospholipid syndrome. Thromb Haemost (1998) 0.81
Fibrinolytic activity during hemodialysis: a biocompatibility-related phenomenon. Kidney Int Suppl (1993) 0.80
Orthopaedic surgery in haemophilia patients with inhibitors as the last resort. Haemophilia (2008) 0.80
[Spanish normative studies in a young adult population (NEURONORMA young adults Project): methods and characteristics of the sample]. Neurologia (2012) 0.80
Intracranial studies on potential generators of some vertex auditory evoked potentials in man. Stereotact Funct Neurosurg (1989) 0.80
Protein C, protein S and C4b-binding protein in neonatal severe infection and septic shock. J Perinat Med (1992) 0.80
Evaluation of the efficacy of lambda-cyhalothrin applied as ultra-low volume and thermal fog for emergency control of Aedes aegypti in Honduras. J Am Mosq Control Assoc (2001) 0.80
Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease. Haematologica (2001) 0.80
Spanish normative studies in young adults (NEURONORMA young adults project): norms for Stroop Color-Word Interference and Tower of London-Drexel University tests. Neurologia (2012) 0.80
Subcortical correlates of the somatic, auditory and visual vertex activities. II. Referential EEG responses. Electroencephalogr Clin Neurophysiol (1986) 0.80
Electrocortical and behavioral responses produced by acute electrical stimulation of the human centromedian thalamic nucleus. Electroencephalogr Clin Neurophysiol (1997) 0.79
Tonometry after laser in situ keratomileusis treatment. J Glaucoma (2001) 0.79
Subthalamic prelemniscal radiation stimulation for the treatment of Parkinson's disease: electrophysiological characterization of the area. Arch Med Res (2000) 0.79
Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol (1996) 0.79
Subcortical correlates of the auditory brain stem potentials in the monkey: bipolar EEG and multiple unit activity responses. Int J Neurosci (1984) 0.79
Elevated levels of tissue factor pathway inhibitor in acute non-lymphoblastic leukemia patients with disseminated intravascular coagulation. Blood Coagul Fibrinolysis (1997) 0.79
Antiphospholipid syndrome and tissue factor: a thrombotic couple. Lupus (2006) 0.79
Spanish version of the Bayer Activities of Daily Living scale in mild cognitive impairment and mild Alzheimer disease: discriminant and concurrent validity. Dement Geriatr Cogn Disord (2009) 0.79
A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department. J Intern Med (2010) 0.79
Seizures induced by penicillin microinjections in the mesencephalic tegmentum. Epilepsy Res (2000) 0.79
The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agents. Haemophilia (2002) 0.79